Eastern Europe, Western Europe, Middle East, Africa, Central America, South America, Asia, North America, Australia
All India
who gmp
Product Description
Molnupiravir is the first oral, direct-acting antiviral shown to be highly effective at reducing nasopharyngeal SARS-CoV-2 infectious virus and viral RNA